Last reviewed · How we verify
NCT05999266
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
trial testing Ultrasonographic Measurements in Rheumatoid Arthritis in 130 participants. Completed in 12 November 2023.
10 November 2023
Quick facts
| Lead sponsor | Sisli Hamidiye Etfal Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 130 |
| Start date | 28 September 2023 |
| Primary completion | 10 November 2023 |
| Estimated completion | 12 November 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Ultrasonographic Measurements
Conditions studied
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
- Knee Pain Chronic — all drugs for Knee Pain Chronic →
- Muscle Loss — all drugs for Muscle Loss →
- Cartilage Degeneration — all drugs for Cartilage Degeneration →
Sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Who can join
Adults 30 to 50, female only, with Rheumatoid Arthritis or Knee Pain Chronic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The knee pain status of the patients who are followed in the rheumatology special branch of the Physical Medicine and Rehabilitation Outpatient Clinic and who meet the inclusion criteria will be questioned. In patients with or without knee pain, the cartilage thickness measurement of the knee joint will be measured from 3 points by ultrasound. At the same time, Quadriceps and Hamstring muscle thickness measurements of the patients will be made from the midpoints where the muscle thickness is the highest. The physician who performed the ultrasonographic measurements of the knee pain status of the patients does not know.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05999266
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rheumatoid Arthritis
Currently open trials in the same condition.
- NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
- NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
- NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting
Other Sisli Hamidiye Etfal Training and Research Hospital trials
Trials by the same sponsor.
- NCT07334002 — The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus · NA · not yet recruiting
- NCT07321041 — Effect of Delivery Time on Umbilical Cord Blood Gas Parameters in Cesarean Sections Under General and Spinal Anesthesia · recruiting
- NCT07476690 — Effect of rESWT Session Frequency on Spasticity and Function Assessed by Sonoelastography in Children With Cerebral Pals · NA · recruiting
- NCT07166614 — Dexmedetomidine vs Propofol in High-Risk ERCP Patients · NA · recruiting
- NCT07250243 — Turkish Validation and Reliability of the John Hopkins In-Room Independence Scale · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05999266 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sisli Hamidiye Etfal Training and Research Hospital
- Last refreshed: 21 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05999266.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing